Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · IEX Real-Time Price · USD
14.98
+0.32 (2.18%)
At close: Apr 19, 2024, 4:00 PM
15.65
+0.67 (4.47%)
After-hours: Apr 19, 2024, 6:46 PM EDT
Tyra Biosciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Tyra Biosciences stock have an average target of 25.33, with a low estimate of 23 and a high estimate of 28. The average target predicts an increase of 69.09% from the current stock price of 14.98.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 21, 2024.
Analyst Ratings
The average analyst rating for TYRA stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $28 | Buy | Reiterates | $28 | +86.92% | Mar 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 → $23 | Strong Buy | Reiterates | $19 → $23 | +53.54% | Mar 20, 2024 |
| Wedbush | Wedbush | Buy Reiterates $27 | Buy | Reiterates | $27 | +80.24% | Dec 29, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +26.84% | Dec 26, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $19 | Strong Buy | Maintains | $20 → $19 | +26.84% | Nov 8, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.92
from -1.62
EPS Next Year
-2.45
from -1.92
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 31.5M | 99.4M | 390.4M |
| Avg | n/a | n/a | 13.8M | 82.1M | 240.1M |
| Low | n/a | n/a | n/a | 51.6M | 166.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 620.6% | 375.3% |
| Avg | - | - | - | 495.5% | 192.3% |
| Low | - | - | - | 274.3% | 102.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.73 | -2.25 | -2.10 | -1.54 | 2.59 |
| Avg | -1.92 | -2.45 | -2.50 | -2.27 | -0.46 |
| Low | -2.02 | -2.94 | -2.90 | -2.58 | -2.17 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.